Myasthenia Gravis Inebilizumab Trial

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

238

Participants

Timeline

Start Date

October 15, 2020

Primary Completion Date

May 28, 2024

Study Completion Date

November 29, 2027

Conditions
Myasthenia Gravis
Interventions
DRUG

inebilizumab

Participants will receive IV inebilizumab

DRUG

IV Placebo

Participants will receive IV placebo matched to inebilizumab

Trial Locations (104)

111

Viela Bio Investigative Site - 4603, Taipei

168

Viela Bio Investigative Site - 3202, Rome

235

Viela Bio Investigative Site 4608, New Taipei City

333

Viela Bio Investigative Site - 4602, Taoyuan

704

Viela Bio Investigative Site - 4606, Tainan City

2100

Viela Bio Investigative Site - 5601, Copenhagen

3722

Viela Bio Investigative Site - 4202, Seoul

5030

Viela Bio Investigative Site - 4203, Seoul

6230

Viela Bio Investigative Site - 3903, Ankara

6351

Viela Bio Investigative Site - 4201, Seoul

8003

Viela Bio Investigative Site - 3402, Barcelona

8916

Viela Bio Investigative Site - 3403, Badalona

10002

Viela Bio Investigative Site - 4604, Taipei

11217

Viela Bio Investigative Site -4607, Taipei

14004

Viela Bio Investigative Site - 3404, Córdoba

15212

Viela Bio Investigative Site - 1008, Pittsburgh

20010

Viela Bio Investigative Center - 1024, Washington D.C.

20122

Viela Bio Investigative Site - 3204, Milan

20133

Viela Bio Investigative Site - 3203, Milan

21050

Viela Bio Investigative Site - 5106, Vinnytsia

23298

Viela Bio Investigative Site - 1006, Richmond

27100

Viela Bio Investigative Site - 3201, Pavia

28203

Viela Bio Investigative Site - 1018, Charlotte

33612

Viela Bio Investigative Site - 1005, Tampa

35100

Viela Bio Investigative Site - 3901, Izmir

35330

Viela Bio Investigative Site - 3902, Izmir

41380

Viela Bio Investigative Site - 3905, Kocaeli

43005

Viela Bio Investigative Site - 5104, Lutsk

43210

Viela Bio Investigative Site - 1009, Columbus

44718

Viela Bio Investigative Site - 1025, Canton

45122

VielaBio Investigative Site - 3101, Essen

45219

Viela Bio Investigative Site - 1001, Cincinnati

49005

Viela Bio Investigative Site - 5103, Dnipro

49089

Viela Bio Investigative Site - 5108, Dnipro

59037

Viela Bio Investigative Site - 3003, Lille

66160

Viela Bio Investigative Site - 1012, Kansas City

67098

Viela Bio Investigative Site - 3002, Strasbourg

76493

Viela Bio Investigative Site - 5105, Ivano-Frankivsk

77030

Viela Bio Investigative Site - 1003, Houston

78229

Viela Bio Investigative Site - 1014, San Antonio

78759

Viela Bio Investigative Site - 1019, Austin

83301

Viela Bio investigative Site - 4605, Kaohsiung City

84132

Viela Bio Investigative Site - 1017, Salt Lake City

92868

Viela Bio Investigative Site - 1015, Orange

100029

Viela Bio Investigative Site 4009, Beijing

100053

Viela Bio Investigative Site - 4007, Beijing

100070

Viela Bio Investigative Site 4003, Beijing

197110

Viela Bio Investigative Site - 5308, Saint Petersburg

201107

Viela Bio Investigative Site - 4006, Shanghai

210009

Viela Bio Investigative Site - 5201, Vitebsk

215006

Viela Bio Investigative Site - 4008, Suzhou

220114

Viela Bio Investigative Site - 5204, Minsk

226014

Viela Bio investigative Site - 4105, Lucknow

230030

Viela Bio Investigative Site - 5203, Grodno

250012

Viela Bio Investigative Site - 4011, Jinan

300052

Viela Bio Investigative Site - 4004, Tianjin

344015

Viela Bio Investigative Site - 5311, Rostov-on-Don

344022

Viela Bio Investigative Site - 5309, Rostov-on-Don

395002

Viela Bio Investigative Site - 4101, Surat

410008

Viela Bio Investigative site 4010, Hunan

411004

Viela Bio Investigative Site - 4109, Pune

422002

Viela Bio Investigative Site - 4102, Nashik

440003

Viela Bio Investigative Site - 4107, Nagpur

440012

Viela Bio Investigative Site - 4113, Nagpur

443095

Viela Bio Investigative Site - 5305, Samara

450083

Viela Bio Investigative Site - 5312, Ufa

500082

Viela Bio Investigative Site - 4112, Hyderabad

550004

Viela Bio Investigative Site - 4005, Guiyang

560002

Viela Bio Investigative Site - 4104, Bangalore

576104

Viela Bio Investigative Site - 4103, Manipal

603126

Viela Bio Investigative Site - 5302, Nizhny Novgorod

630087

Viela Bio Investigative Site - 5304, Novosibirsk

656043

Viela Bio Investigative Site - 5313, Barnaul

656045

Viela Bio Investigative Site - 5303, Barnaul

710038

Viela Bio Investigative Site 4012, Xi'an

06519

Viela Bio Investigative Site - 1002, New Haven

05401

Viela Bio Investigative Site - 1004, Burlington

C1023AAB

Viela Bio Investigative Site - 2001, Buenos Aires

C1199ABB

VielaBio Investigative Site - 2002, Buenos Aires

C1221ADC

Viela Bio Investigative Site - 2003, Buenos Aires

90035-001

VielaBio Investigative Site - 2201, Porto Alegre

90840-440

VielaBio Investigative Site - 2203, Porto Alegre

14051-140

VielaBio Investigative Site - 2207, Ribeirão Preto

01228-000

VielaBio Investigative Site - 2206, São Paulo

08270-120

Viela Bio Investigative Site - 2205, São Paulo

M5G 2C4

Viela Bio Investigative Site - 1102, Toronto

H2X 3J4

Viela Bio Investigative Site - 1101, Montreal

H3A 2B4

Viela Bio Investigative Site - 1103, Montreal

06001

Viela Bio Investigative Site - 3001, Nice

260-8677

Viela Bio Investigative Site - 4402, Chiba

286-8520

Viela Bio Investigative Site - 4410, Chiba

812-8582

Viela Bio Investigative Site 4409, Fukuoka

025-0082

Viela Bio Investigative Site - 4401, Hanamaki

041-8680

VielaBio Investigative Site - 4408, Hokkaido

663-8501

Viela Bio Investigative Site - 4406, Hyōgo

983-8520

Viela Bio Investigative Site 4405, Miyagi

570-8507

Viela Bio Investigative Site - 4413, Moriguchi

020-8505

VielaBio Investigative Site - 4407, Morioka

350-8550

Viela Bio Investigative Site - 4404, Saitama

40-635

Viela Bio Investigative Site - 3302, Katowice

40-752

Viela Bio Investigative Site - 3303, Katowice

31-505

Viela Bio Investigative Site - 3301, Krakow

60-693

Med Polonia Sp. z o.o - 3311, Poznan

01-868

Viela Bio Investigative Site - 3310, Warsaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT04524273 - Myasthenia Gravis Inebilizumab Trial | Biotech Hunter | Biotech Hunter